NCT00075426已完成2 期
A Pilot Phase II Protocol Of Arsenic Trioxide (Trisenox) In Subjects With Advanced Non-Small Cell Carcinoma Of The Lung
适应症
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 30
- 试验地点
- 2
研究概览
简要总结
RATIONALE: Drugs used in chemotherapy, such as arsenic trioxide, use different ways to stop tumor cells from dividing so they stop growing or die.
PURPOSE: This phase II trial is studying how well arsenic trioxide works in treating patients with locally advanced or metastatic non-small cell lung cancer.
详细描述
OBJECTIVES:
Primary
- Determine the safety and activity of arsenic trioxide in patients with locally advanced or metastatic non-small cell lung cancer.
- Determine the qualitative and quantitative toxic effects of this drug in these patients.
Secondary
- Determine the response, in terms of objective tumor response and response duration, in patients treated with this drug.
- Determine the patterns of failure and survival in patients treated with this drug.
研究设计
- 研究类型
- Interventional
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究者
研究点 (2)
Loading locations...
相似试验
撤回
2 期
Arsenic Trioxide in Treating Women With Locally Advanced or Metastatic Breast CancerBreast CancerNCT00075413The University of Texas Medical Branch, Galveston
已完成
1 期
Arsenic Trioxide and Radiation Therapy in Treating Young Patients With Newly Diagnosed GliomasBrain and Central Nervous System TumorsNCT00095771Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins36
终止
2 期
Arsenic Trioxide and Cholecalciferol (Vitamin D) in Treating Patients With Myelodysplastic SyndromesMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative NeoplasmsLeukemiaNCT00104806Wake Forest University Health Sciences5
已完成
1 期
Arsenic Trioxide Plus Vitamin C in Treating Patients With Recurrent or Refractory Multiple MyelomaMultiple Myeloma and Plasma Cell NeoplasmNCT00006021University of Miami22
已完成
2 期
Arsenic Trioxide in Treating Patients With Relapsed or Refractory Acute Lymphoblastic LeukemiaLeukemiaNCT00006008Eastern Cooperative Oncology Group